nodes	percent_of_prediction	percent_of_DWPC	metapath
Ospemifene—ESR1—uterine cancer	0.437	1	CbGaD
Ospemifene—ESR1—Medroxyprogesterone Acetate—uterine cancer	0.211	0.419	CbGbCtD
Ospemifene—ESR1—Progesterone—uterine cancer	0.14	0.278	CbGbCtD
Ospemifene—CYP2C9—Medroxyprogesterone Acetate—uterine cancer	0.0374	0.074	CbGbCtD
Ospemifene—CYP2C19—Progesterone—uterine cancer	0.0298	0.059	CbGbCtD
Ospemifene—CYP2C9—Progesterone—uterine cancer	0.0247	0.049	CbGbCtD
Ospemifene—CYP3A4—Medroxyprogesterone Acetate—uterine cancer	0.0217	0.043	CbGbCtD
Ospemifene—CYP3A4—Progesterone—uterine cancer	0.0144	0.0285	CbGbCtD
Ospemifene—CYP2B6—Doxorubicin—uterine cancer	0.0143	0.0283	CbGbCtD
Ospemifene—CYP3A4—Etoposide—uterine cancer	0.00644	0.0128	CbGbCtD
Ospemifene—CYP3A4—Doxorubicin—uterine cancer	0.00439	0.0087	CbGbCtD
Ospemifene—Vaginal discharge—Progesterone—uterine cancer	0.00257	0.0696	CcSEcCtD
Ospemifene—Cerebral haemorrhage—Medroxyprogesterone Acetate—uterine cancer	0.00255	0.0693	CcSEcCtD
Ospemifene—Vaginal discharge—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.063	CcSEcCtD
Ospemifene—Deep vein thrombosis—Medroxyprogesterone Acetate—uterine cancer	0.00232	0.063	CcSEcCtD
Ospemifene—Neoplasm malignant—Progesterone—uterine cancer	0.00183	0.0496	CcSEcCtD
Ospemifene—Neoplasm malignant—Medroxyprogesterone Acetate—uterine cancer	0.00166	0.0449	CcSEcCtD
Ospemifene—Hot flush—Progesterone—uterine cancer	0.00121	0.0328	CcSEcCtD
Ospemifene—Menopausal symptoms—Progesterone—uterine cancer	0.0012	0.0326	CcSEcCtD
Ospemifene—Hot flush—Medroxyprogesterone Acetate—uterine cancer	0.0011	0.0298	CcSEcCtD
Ospemifene—Menopausal symptoms—Medroxyprogesterone Acetate—uterine cancer	0.00109	0.0295	CcSEcCtD
Ospemifene—ESR1—oviduct—uterine cancer	0.00107	0.219	CbGeAlD
Ospemifene—Breast disorder—Progesterone—uterine cancer	0.00102	0.0278	CcSEcCtD
Ospemifene—Clomifene—CYP11A1—uterine cancer	0.000977	0.257	CrCbGaD
Ospemifene—Breast disorder—Medroxyprogesterone Acetate—uterine cancer	0.000928	0.0252	CcSEcCtD
Ospemifene—Cardiovascular disorder—Etoposide—uterine cancer	0.000909	0.0246	CcSEcCtD
Ospemifene—Connective tissue disorder—Progesterone—uterine cancer	0.00077	0.0209	CcSEcCtD
Ospemifene—Vaginal discharge—Epirubicin—uterine cancer	0.000736	0.0199	CcSEcCtD
Ospemifene—Angiopathy—Progesterone—uterine cancer	0.000711	0.0193	CcSEcCtD
Ospemifene—Connective tissue disorder—Medroxyprogesterone Acetate—uterine cancer	0.000698	0.0189	CcSEcCtD
Ospemifene—Vaginal discharge—Doxorubicin—uterine cancer	0.000681	0.0185	CcSEcCtD
Ospemifene—Muscle spasms—Progesterone—uterine cancer	0.000656	0.0178	CcSEcCtD
Ospemifene—Angiopathy—Medroxyprogesterone Acetate—uterine cancer	0.000644	0.0175	CcSEcCtD
Ospemifene—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000594	0.0161	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000577	0.0156	CcSEcCtD
Ospemifene—Skin disorder—Progesterone—uterine cancer	0.000541	0.0147	CcSEcCtD
Ospemifene—Hyperhidrosis—Progesterone—uterine cancer	0.000538	0.0146	CcSEcCtD
Ospemifene—Toremifene—ESR1—uterine cancer	0.000538	0.141	CrCbGaD
Ospemifene—Bifonazole—CYP19A1—uterine cancer	0.000525	0.138	CrCbGaD
Ospemifene—Neoplasm malignant—Epirubicin—uterine cancer	0.000524	0.0142	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000523	0.0142	CcSEcCtD
Ospemifene—Cardiovascular disorder—Epirubicin—uterine cancer	0.000509	0.0138	CcSEcCtD
Ospemifene—Clomifene—CYP19A1—uterine cancer	0.000505	0.133	CrCbGaD
Ospemifene—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.00049	0.0133	CcSEcCtD
Ospemifene—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000488	0.0132	CcSEcCtD
Ospemifene—Neoplasm malignant—Doxorubicin—uterine cancer	0.000485	0.0131	CcSEcCtD
Ospemifene—Cardiovascular disorder—Doxorubicin—uterine cancer	0.000471	0.0128	CcSEcCtD
Ospemifene—Clomifene—ESR1—uterine cancer	0.000465	0.122	CrCbGaD
Ospemifene—Angiopathy—Etoposide—uterine cancer	0.000364	0.00986	CcSEcCtD
Ospemifene—Tamoxifen—ESR2—uterine cancer	0.000349	0.0916	CrCbGaD
Ospemifene—Hot flush—Epirubicin—uterine cancer	0.000347	0.00942	CcSEcCtD
Ospemifene—Menopausal symptoms—Epirubicin—uterine cancer	0.000344	0.00933	CcSEcCtD
Ospemifene—ESR1—myometrium—uterine cancer	0.000342	0.0701	CbGeAlD
Ospemifene—Muscle spasms—Etoposide—uterine cancer	0.000336	0.0091	CcSEcCtD
Ospemifene—Hot flush—Doxorubicin—uterine cancer	0.000321	0.00871	CcSEcCtD
Ospemifene—Menopausal symptoms—Doxorubicin—uterine cancer	0.000319	0.00864	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000295	0.008	CcSEcCtD
Ospemifene—Breast disorder—Epirubicin—uterine cancer	0.000294	0.00796	CcSEcCtD
Ospemifene—Skin disorder—Etoposide—uterine cancer	0.000277	0.0075	CcSEcCtD
Ospemifene—Hyperhidrosis—Etoposide—uterine cancer	0.000275	0.00747	CcSEcCtD
Ospemifene—Breast disorder—Doxorubicin—uterine cancer	0.000272	0.00736	CcSEcCtD
Ospemifene—ESR1—epithelium—uterine cancer	0.000269	0.055	CbGeAlD
Ospemifene—ESR1—uterine cervix—uterine cancer	0.000266	0.0546	CbGeAlD
Ospemifene—ESR1—smooth muscle tissue—uterine cancer	0.000259	0.053	CbGeAlD
Ospemifene—ESR1—decidua—uterine cancer	0.000254	0.052	CbGeAlD
Ospemifene—ESR1—renal system—uterine cancer	0.000249	0.051	CbGeAlD
Ospemifene—ESR1—endometrium—uterine cancer	0.000241	0.0493	CbGeAlD
Ospemifene—Tamoxifen—CYP19A1—uterine cancer	0.000233	0.0613	CrCbGaD
Ospemifene—ESR1—uterus—uterine cancer	0.000222	0.0455	CbGeAlD
Ospemifene—Connective tissue disorder—Epirubicin—uterine cancer	0.000221	0.00599	CcSEcCtD
Ospemifene—Tamoxifen—ESR1—uterine cancer	0.000215	0.0564	CrCbGaD
Ospemifene—Connective tissue disorder—Doxorubicin—uterine cancer	0.000204	0.00554	CcSEcCtD
Ospemifene—Angiopathy—Epirubicin—uterine cancer	0.000204	0.00553	CcSEcCtD
Ospemifene—ESR1—female reproductive system—uterine cancer	0.0002	0.0409	CbGeAlD
Ospemifene—Angiopathy—Doxorubicin—uterine cancer	0.000189	0.00512	CcSEcCtD
Ospemifene—Muscle spasms—Epirubicin—uterine cancer	0.000188	0.0051	CcSEcCtD
Ospemifene—CYP2B6—renal system—uterine cancer	0.000184	0.0377	CbGeAlD
Ospemifene—ESR1—female gonad—uterine cancer	0.000182	0.0372	CbGeAlD
Ospemifene—ESR1—vagina—uterine cancer	0.000181	0.037	CbGeAlD
Ospemifene—Muscle spasms—Doxorubicin—uterine cancer	0.000174	0.00472	CcSEcCtD
Ospemifene—CYP2C19—vagina—uterine cancer	0.00017	0.0349	CbGeAlD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000165	0.00448	CcSEcCtD
Ospemifene—Skin disorder—Epirubicin—uterine cancer	0.000155	0.00421	CcSEcCtD
Ospemifene—Hyperhidrosis—Epirubicin—uterine cancer	0.000154	0.00419	CcSEcCtD
Ospemifene—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000153	0.00415	CcSEcCtD
Ospemifene—CYP2B6—female reproductive system—uterine cancer	0.000148	0.0302	CbGeAlD
Ospemifene—CYP2C9—female reproductive system—uterine cancer	0.000146	0.0299	CbGeAlD
Ospemifene—Skin disorder—Doxorubicin—uterine cancer	0.000144	0.00389	CcSEcCtD
Ospemifene—Hyperhidrosis—Doxorubicin—uterine cancer	0.000143	0.00387	CcSEcCtD
Ospemifene—CYP3A4—renal system—uterine cancer	0.000139	0.0285	CbGeAlD
Ospemifene—CYP2B6—vagina—uterine cancer	0.000133	0.0273	CbGeAlD
Ospemifene—ESR1—lymph node—uterine cancer	0.000117	0.0239	CbGeAlD
Ospemifene—CYP3A4—female reproductive system—uterine cancer	0.000111	0.0228	CbGeAlD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—SMAD3—uterine cancer	8.9e-05	0.00676	CbGpPWpGaD
Ospemifene—ESR1—Estrogen signaling pathway—PIK3CA—uterine cancer	8.78e-05	0.00667	CbGpPWpGaD
Ospemifene—CYP2C19—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	8.25e-05	0.00627	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—PGR—uterine cancer	8.22e-05	0.00625	CbGpPWpGaD
Ospemifene—ESR1—FOXA1 transcription factor network—CDKN1B—uterine cancer	8.04e-05	0.00611	CbGpPWpGaD
Ospemifene—CYP2B6—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	8.04e-05	0.00611	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—AKR1B10—uterine cancer	7.77e-05	0.00591	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—CDKN1B—uterine cancer	7.76e-05	0.0059	CbGpPWpGaD
Ospemifene—CYP2C9—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	7.53e-05	0.00572	CbGpPWpGaD
Ospemifene—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	7.49e-05	0.00569	CbGpPWpGaD
Ospemifene—CYP2C19—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	7.39e-05	0.00562	CbGpPWpGaD
Ospemifene—ESR1—FOXM1 transcription factor network—EP300—uterine cancer	7.33e-05	0.00557	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—AKR1B1—uterine cancer	7.23e-05	0.00549	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—CCL2—uterine cancer	7.18e-05	0.00546	CbGpPWpGaD
Ospemifene—ESR1—Estrogen signaling pathway—AKT1—uterine cancer	7.17e-05	0.00545	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—AKR1B10—uterine cancer	7.09e-05	0.00539	CbGpPWpGaD
Ospemifene—ESR1—FOXA1 transcription factor network—EP300—uterine cancer	7.06e-05	0.00537	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—AKR1C1—uterine cancer	7.02e-05	0.00534	CbGpPWpGaD
Ospemifene—ESR1—Plasma membrane estrogen receptor signaling—NRAS—uterine cancer	6.99e-05	0.00531	CbGpPWpGaD
Ospemifene—CYP2C9—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	6.83e-05	0.00519	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—EP300—uterine cancer	6.81e-05	0.00518	CbGpPWpGaD
Ospemifene—CYP2C9—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	6.74e-05	0.00512	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—STK11—uterine cancer	6.6e-05	0.00502	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—CYP19A1—uterine cancer	6.6e-05	0.00502	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—AKR1B1—uterine cancer	6.59e-05	0.00501	CbGpPWpGaD
Ospemifene—ESR1—ATF-2 transcription factor network—CXCL8—uterine cancer	6.51e-05	0.00495	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—EZH2—uterine cancer	6.5e-05	0.00494	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—VEGFA—uterine cancer	6.45e-05	0.00491	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—NRAS—uterine cancer	6.38e-05	0.00485	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—CDKN2A—uterine cancer	6.26e-05	0.00476	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—GPX3—uterine cancer	6.16e-05	0.00468	CbGpPWpGaD
Ospemifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP11A1—uterine cancer	6.12e-05	0.00465	CbGpPWpGaD
Ospemifene—CYP2C19—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	6.07e-05	0.00462	CbGpPWpGaD
Ospemifene—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—uterine cancer	6.07e-05	0.00461	CbGpPWpGaD
Ospemifene—CYP3A4—Oxidation by Cytochrome P450—CYP11A1—uterine cancer	6.04e-05	0.00459	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—ESR2—uterine cancer	6.03e-05	0.00458	CbGpPWpGaD
Ospemifene—ESR1—Plasma membrane estrogen receptor signaling—KRAS—uterine cancer	6.02e-05	0.00457	CbGpPWpGaD
Ospemifene—CYP2B6—Biological oxidations—CYP11A1—uterine cancer	5.8e-05	0.00441	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—CYP11A1—uterine cancer	5.72e-05	0.00435	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—CXCL8—uterine cancer	5.68e-05	0.00432	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—CDKN1B—uterine cancer	5.68e-05	0.00431	CbGpPWpGaD
Ospemifene—ESR1—Leptin signaling pathway—ERBB2—uterine cancer	5.67e-05	0.00431	CbGpPWpGaD
Ospemifene—ESR1—ATF-2 transcription factor network—EP300—uterine cancer	5.58e-05	0.00424	CbGpPWpGaD
Ospemifene—CYP3A4—Tryptophan metabolism—CYP19A1—uterine cancer	5.57e-05	0.00423	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—CDKN1B—uterine cancer	5.55e-05	0.00422	CbGpPWpGaD
Ospemifene—CYP2C9—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	5.54e-05	0.00421	CbGpPWpGaD
Ospemifene—ESR1—Plasma membrane estrogen receptor signaling—PIK3CA—uterine cancer	5.53e-05	0.0042	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—KRAS—uterine cancer	5.49e-05	0.00417	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—STK11—uterine cancer	5.47e-05	0.00416	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—AKR1C3—uterine cancer	5.4e-05	0.00411	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—AKR1C1—uterine cancer	5.31e-05	0.00403	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—CTNNB1—uterine cancer	5.24e-05	0.00398	CbGpPWpGaD
Ospemifene—ESR1—Validated nuclear estrogen receptor alpha network—EP300—uterine cancer	5.23e-05	0.00398	CbGpPWpGaD
Ospemifene—ESR1—LKB1 signaling events—TP53—uterine cancer	5.15e-05	0.00391	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—FGFR2—uterine cancer	5.13e-05	0.0039	CbGpPWpGaD
Ospemifene—ESR1—Plasma membrane estrogen receptor signaling—HRAS—uterine cancer	5.11e-05	0.00389	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—PTEN—uterine cancer	5.11e-05	0.00388	CbGpPWpGaD
Ospemifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP11A1—uterine cancer	4.96e-05	0.00377	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN2B—uterine cancer	4.91e-05	0.00373	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—EP300—uterine cancer	4.87e-05	0.0037	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—AKR1C1—uterine cancer	4.84e-05	0.00368	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—AKR1B10—uterine cancer	4.68e-05	0.00355	CbGpPWpGaD
Ospemifene—ESR1—Aryl Hydrocarbon Receptor—HRAS—uterine cancer	4.66e-05	0.00354	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—GPX3—uterine cancer	4.66e-05	0.00354	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—PHF1—uterine cancer	4.61e-05	0.00351	CbGpPWpGaD
Ospemifene—ESR1—Plasma membrane estrogen receptor signaling—AKT1—uterine cancer	4.52e-05	0.00343	CbGpPWpGaD
Ospemifene—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—uterine cancer	4.5e-05	0.00342	CbGpPWpGaD
Ospemifene—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—uterine cancer	4.45e-05	0.00338	CbGpPWpGaD
Ospemifene—CYP2C19—Biological oxidations—CYP11A1—uterine cancer	4.38e-05	0.00333	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—AKR1B1—uterine cancer	4.35e-05	0.0033	CbGpPWpGaD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—EP300—uterine cancer	4.33e-05	0.00329	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—CYP11A1—uterine cancer	4.32e-05	0.00329	CbGpPWpGaD
Ospemifene—CYP2B6—Biological oxidations—CYP19A1—uterine cancer	4.27e-05	0.00324	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—GPX3—uterine cancer	4.25e-05	0.00323	CbGpPWpGaD
Ospemifene—CYP2B6—Metapathway biotransformation—CYP19A1—uterine cancer	4.21e-05	0.0032	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—AKR1C3—uterine cancer	4.08e-05	0.0031	CbGpPWpGaD
Ospemifene—CYP2C9—Biological oxidations—CYP11A1—uterine cancer	4e-05	0.00304	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—CYP11A1—uterine cancer	3.94e-05	0.003	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—CHD4—uterine cancer	3.92e-05	0.00298	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.89e-05	0.00296	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—CDH1—uterine cancer	3.84e-05	0.00292	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—AKR1C3—uterine cancer	3.72e-05	0.00283	CbGpPWpGaD
Ospemifene—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—uterine cancer	3.65e-05	0.00278	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—SRD5A2—uterine cancer	3.55e-05	0.0027	CbGpPWpGaD
Ospemifene—ESR1—AP-1 transcription factor network—TP53—uterine cancer	3.49e-05	0.00265	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—PGR—uterine cancer	3.4e-05	0.00258	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—SUZ12—uterine cancer	3.29e-05	0.0025	CbGpPWpGaD
Ospemifene—CYP2C19—Biological oxidations—CYP19A1—uterine cancer	3.23e-05	0.00245	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—ERBB2—uterine cancer	3.22e-05	0.00245	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—AKR1C1—uterine cancer	3.19e-05	0.00242	CbGpPWpGaD
Ospemifene—CYP2C19—Metapathway biotransformation—CYP19A1—uterine cancer	3.18e-05	0.00242	CbGpPWpGaD
Ospemifene—ESR1—Leptin signaling pathway—HRAS—uterine cancer	3.15e-05	0.0024	CbGpPWpGaD
Ospemifene—ESR1—Regulation of Telomerase—AKT1—uterine cancer	3.01e-05	0.00229	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—ESR2—uterine cancer	2.99e-05	0.00228	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—CDKN1B—uterine cancer	2.98e-05	0.00227	CbGpPWpGaD
Ospemifene—CYP2C9—Biological oxidations—CYP19A1—uterine cancer	2.94e-05	0.00224	CbGpPWpGaD
Ospemifene—CYP2C9—Metapathway biotransformation—CYP19A1—uterine cancer	2.9e-05	0.0022	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—CTNNB1—uterine cancer	2.83e-05	0.00215	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.81e-05	0.00214	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.81e-05	0.00214	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—GPX3—uterine cancer	2.8e-05	0.00213	CbGpPWpGaD
Ospemifene—ESR1—Leptin signaling pathway—AKT1—uterine cancer	2.79e-05	0.00212	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—PTEN—uterine cancer	2.76e-05	0.0021	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—PTEN—uterine cancer	2.75e-05	0.00209	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—ERBB2—uterine cancer	2.68e-05	0.00204	CbGpPWpGaD
Ospemifene—CYP3A4—Biological oxidations—CYP11A1—uterine cancer	2.64e-05	0.002	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—EP300—uterine cancer	2.63e-05	0.002	CbGpPWpGaD
Ospemifene—ESR1—Regulation of nuclear SMAD2/3 signaling—AKT1—uterine cancer	2.62e-05	0.00199	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—CYP11A1—uterine cancer	2.6e-05	0.00198	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—STAR—uterine cancer	2.57e-05	0.00195	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1B1—uterine cancer	2.57e-05	0.00195	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—VEGFA—uterine cancer	2.49e-05	0.0019	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—CDKN1B—uterine cancer	2.48e-05	0.00189	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—AKR1C3—uterine cancer	2.46e-05	0.00187	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—NRAS—uterine cancer	2.45e-05	0.00186	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—CDKN2B—uterine cancer	2.44e-05	0.00185	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—uterine cancer	2.35e-05	0.00178	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—NDUFB11—uterine cancer	2.29e-05	0.00174	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—SRD5A2—uterine cancer	2.29e-05	0.00174	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—PTEN—uterine cancer	2.29e-05	0.00174	CbGpPWpGaD
Ospemifene—ESR1—Generic Transcription Pathway—SMAD3—uterine cancer	2.23e-05	0.00169	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—EP300—uterine cancer	2.18e-05	0.00166	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—KRAS—uterine cancer	2.12e-05	0.00161	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—KRAS—uterine cancer	2.11e-05	0.0016	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—AKR1B10—uterine cancer	2.08e-05	0.00158	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—VEGFA—uterine cancer	2.07e-05	0.00157	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	2.07e-05	0.00157	CbGpPWpGaD
Ospemifene—CYP3A4—Biological oxidations—CYP19A1—uterine cancer	1.94e-05	0.00147	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—PIK3CA—uterine cancer	1.94e-05	0.00147	CbGpPWpGaD
Ospemifene—CYP3A4—Metapathway biotransformation—CYP19A1—uterine cancer	1.91e-05	0.00145	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—TP53—uterine cancer	1.88e-05	0.00143	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C1—uterine cancer	1.88e-05	0.00143	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—HRAS—uterine cancer	1.79e-05	0.00136	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—KRAS—uterine cancer	1.76e-05	0.00134	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—SRD5A2—uterine cancer	1.73e-05	0.00132	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—NDUFB11—uterine cancer	1.73e-05	0.00132	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—RNF43—uterine cancer	1.72e-05	0.00131	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.68e-05	0.00128	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—AKR1B1—uterine cancer	1.66e-05	0.00126	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—STAR—uterine cancer	1.66e-05	0.00126	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—PGR—uterine cancer	1.64e-05	0.00124	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—uterine cancer	1.61e-05	0.00123	CbGpPWpGaD
Ospemifene—ESR1—Integrated Breast Cancer Pathway—AKT1—uterine cancer	1.59e-05	0.00121	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.59e-05	0.00121	CbGpPWpGaD
Ospemifene—ESR1—Signaling by ERBB4—AKT1—uterine cancer	1.58e-05	0.0012	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—NDUFB11—uterine cancer	1.58e-05	0.0012	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—SRD5A2—uterine cancer	1.58e-05	0.0012	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—INHBA—uterine cancer	1.58e-05	0.0012	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—TP53—uterine cancer	1.56e-05	0.00119	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—EZH2—uterine cancer	1.56e-05	0.00118	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—CYP11A1—uterine cancer	1.54e-05	0.00117	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—AKR1C3—uterine cancer	1.45e-05	0.0011	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—ESR2—uterine cancer	1.44e-05	0.0011	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—AKR1C1—uterine cancer	1.42e-05	0.00108	CbGpPWpGaD
Ospemifene—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—uterine cancer	1.32e-05	0.001	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—POLD1—uterine cancer	1.3e-05	0.000989	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—AKR1B1—uterine cancer	1.25e-05	0.000953	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—STAR—uterine cancer	1.25e-05	0.000953	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.24e-05	0.000942	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—AKR1C1—uterine cancer	1.22e-05	0.000925	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—CDKN2B—uterine cancer	1.17e-05	0.000892	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—STAR—uterine cancer	1.14e-05	0.000869	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—AKR1B1—uterine cancer	1.14e-05	0.000869	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—CYP19A1—uterine cancer	1.13e-05	0.000859	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—AKR1C3—uterine cancer	1.09e-05	0.00083	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—RRM2—uterine cancer	1.08e-05	0.000825	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—SMAD3—uterine cancer	1.07e-05	0.000814	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PGR—uterine cancer	1.06e-05	0.000809	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—DCN—uterine cancer	1.05e-05	0.000801	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—NDUFB11—uterine cancer	1.04e-05	0.000792	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—SRD5A2—uterine cancer	1.04e-05	0.000792	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—YWHAE—uterine cancer	1.02e-05	0.000772	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CYP11A1—uterine cancer	9.92e-06	0.000754	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—POLD1—uterine cancer	9.83e-06	0.000747	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FBXW7—uterine cancer	9.74e-06	0.00074	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—AKR1C3—uterine cancer	9.37e-06	0.000712	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—AKR1C1—uterine cancer	9.2e-06	0.000699	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—POLD1—uterine cancer	8.97e-06	0.000682	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—STK11—uterine cancer	8.51e-06	0.000647	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—AKR1C1—uterine cancer	8.39e-06	0.000637	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—RRM2—uterine cancer	8.2e-06	0.000623	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—SOCS3—uterine cancer	7.97e-06	0.000606	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—DCN—uterine cancer	7.96e-06	0.000605	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CDKN2B—uterine cancer	7.63e-06	0.00058	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—STAR—uterine cancer	7.54e-06	0.000573	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—AKR1B1—uterine cancer	7.54e-06	0.000573	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CYP11A1—uterine cancer	7.5e-06	0.00057	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—RRM2—uterine cancer	7.48e-06	0.000568	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—IGF1R—uterine cancer	7.41e-06	0.000563	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—STK11—uterine cancer	7.3e-06	0.000555	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—CYP19A1—uterine cancer	7.3e-06	0.000555	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—DCN—uterine cancer	7.26e-06	0.000552	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—AKR1C3—uterine cancer	7.08e-06	0.000538	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—SMAD3—uterine cancer	6.97e-06	0.000529	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CYP11A1—uterine cancer	6.84e-06	0.00052	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—FGFR2—uterine cancer	6.64e-06	0.000505	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—AKR1C3—uterine cancer	6.46e-06	0.000491	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—POLD1—uterine cancer	5.91e-06	0.000449	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—AKR1C1—uterine cancer	5.53e-06	0.00042	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—CYP19A1—uterine cancer	5.52e-06	0.000419	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—STK11—uterine cancer	5.52e-06	0.000419	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—MTHFR—uterine cancer	5.49e-06	0.000417	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	5.18e-06	0.000394	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—STK11—uterine cancer	5.03e-06	0.000382	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—CYP19A1—uterine cancer	5.03e-06	0.000382	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CCL2—uterine cancer	5e-06	0.00038	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.94e-06	0.000375	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—RRM2—uterine cancer	4.93e-06	0.000375	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—DCN—uterine cancer	4.79e-06	0.000364	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—uterine cancer	4.72e-06	0.000359	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CYP11A1—uterine cancer	4.51e-06	0.000343	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—EP300—uterine cancer	4.5e-06	0.000342	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—AKR1C3—uterine cancer	4.26e-06	0.000324	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—ERBB2—uterine cancer	4.17e-06	0.000317	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—MTHFR—uterine cancer	4.15e-06	0.000315	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CXCL8—uterine cancer	3.96e-06	0.000301	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CDKN1B—uterine cancer	3.86e-06	0.000294	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—MTHFR—uterine cancer	3.78e-06	0.000287	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.65e-06	0.000278	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—CTNNB1—uterine cancer	3.65e-06	0.000277	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PTEN—uterine cancer	3.56e-06	0.00027	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—EP300—uterine cancer	3.39e-06	0.000258	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—uterine cancer	3.33e-06	0.000253	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—CYP19A1—uterine cancer	3.32e-06	0.000252	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—STK11—uterine cancer	3.32e-06	0.000252	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—VEGFA—uterine cancer	3.21e-06	0.000244	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—NRAS—uterine cancer	3.17e-06	0.000241	CbGpPWpGaD
Ospemifene—ESR1—Gene Expression—AKT1—uterine cancer	3.15e-06	0.00024	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PTEN—uterine cancer	3.05e-06	0.000232	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—EP300—uterine cancer	2.91e-06	0.000221	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—KRAS—uterine cancer	2.73e-06	0.000208	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—PIK3CA—uterine cancer	2.51e-06	0.000191	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—MTHFR—uterine cancer	2.49e-06	0.000189	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—TP53—uterine cancer	2.43e-06	0.000185	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—HRAS—uterine cancer	2.32e-06	0.000176	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PTEN—uterine cancer	2.31e-06	0.000175	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—EP300—uterine cancer	2.2e-06	0.000167	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—PIK3CA—uterine cancer	2.15e-06	0.000164	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PTEN—uterine cancer	2.1e-06	0.00016	CbGpPWpGaD
Ospemifene—ESR1—Signaling Pathways—AKT1—uterine cancer	2.05e-06	0.000156	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—EP300—uterine cancer	2.01e-06	0.000152	CbGpPWpGaD
Ospemifene—CYP2B6—Metabolism—AKT1—uterine cancer	1.76e-06	0.000134	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—PIK3CA—uterine cancer	1.63e-06	0.000124	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—PIK3CA—uterine cancer	1.48e-06	0.000113	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PTEN—uterine cancer	1.39e-06	0.000105	CbGpPWpGaD
Ospemifene—CYP2C19—Metabolism—AKT1—uterine cancer	1.33e-06	0.000101	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—EP300—uterine cancer	1.32e-06	0.000101	CbGpPWpGaD
Ospemifene—CYP2C9—Metabolism—AKT1—uterine cancer	1.21e-06	9.21e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—PIK3CA—uterine cancer	9.78e-07	7.44e-05	CbGpPWpGaD
Ospemifene—CYP3A4—Metabolism—AKT1—uterine cancer	7.99e-07	6.07e-05	CbGpPWpGaD
